NEW YORK (Reuters Health) – A central pulse pressure (PP) of 50 mmHg or higher is predictive of future MI, coronary heart disease, and other cardiovascular events, according…
NEW YORK (Reuters Health) – Adding a basal or prandial insulin-based regimen to oral therapy may enhance glycemic control in patients with type 2 diabetes, according to a…
NEW YORK (Reuters Health) – Omega-3 fatty acid supplements do not improve the response to sertraline in heart disease patients with major depression, according to results of a…
NEW YORK (Reuters Health) – Patients with heart failure have fewer hospitalizations and lower mortality when they’re monitored remotely, either by routine telephone calls or electronic transfer of…
NEW YORK (Reuters Health) – Whether the catheter is removed or not has no bearing on the resolution of catheter-related coagulase-negative staphylococcal bacteremia following treatment with antimicrobial therapy,…
NEW YORK (Reuters Health) – Percutaneous intervention may not be necessary for the majority of hypertensive patients with atherosclerotic renovascular disease. In a large retrospective study, researchers from…
NEW YORK (Reuters Health) – The results of a systematic review suggest that use of an ACE inhibitor reduces total mortality and the risk of nonfatal MI in…
NEW YORK (Reuters Health) – Neoadjuvant treatment with erlotinib (Tarceva), an epidermal growth factor receptor (EGFR) inhibitor, can help downstage bladder cancer to organ-confined disease, thereby increasing the…
NEW YORK (Reuters Health) – Elevated pre-operative blood levels of brain natriuretic peptide (BNP) or N-terminal-proBNP identify patients who are at increased risk for cardiovascular events within 30…
NEW YORK (Reuters Health) – While minimally invasive radical prostatectomy (MIRP) offers certain advantages over open retropubic radical prostatectomy (RRP), such as a shorter hospital stay, it also…
